Downloading...
Download
BIOTRON LIMITEDBIOTRON LIMITEDBIOTRON LIMITED

BIOTRON LIMITED

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals

BIT trade ideas

Finer Market Points: ASX Top 10 Momentum Stocks: 31 Oct 2023NYSE:DTC NASDAQ:BNR ASX:LPI TSX:DXB EURONEXT:EGR ASX:VMM ASX:DCN NYSE:STK NYSE:BIT TSX:KRR Momentum leading shares are the market's best performers today. They are the fastest-growing shares on the ASX over the last 90 days. These companies can't get to be leaders without first appearing on our Launch Pad list. The Launch Pad List is published weekly on Fridays. Today's ASX's Top 10 Quarterly Momentum Stocks are: Dacian Gold Limited (DCN): Gold explorer and developer with a 2.9Mtpa processing facility in the Leonora region of WA. Bulletin Resources Ltd (BNR): An explorer seeking projects within a haulage distance to existing infrastructure, operating mines, or advanced projects. They are currently working on a lithium spodumene project near Mt Cattlin and the Lake Rebecca gold project, both within close proximity to other known and existing mines. Lithium Power International Ltd (LPI): Lithium Power International Limited is a company focused on lithium, with projects in Chile and Western Australia. Dimerix Ltd (DXB): Dimerix Limited is a clinical-stage biopharmaceutical company specializing in inflammatory diseases, including both kidney and respiratory diseases. Dimerix is currently focused on developing its proprietary Phase 3 product candidate DMX-200. Ecograf Limited (EGR): Ecograf Limited is an advanced battery graphite company, vertically integrated from resource development in Australia and Tanzania through to battery anode material production and recovery & re-use with a closed-loop recycling process. Viridismining (VMM): Viridis Mining and Minerals Limited is exploring gold, Ni, Cu, PGE, and Kaloin-halloysite assets in Canada and WA SA and NSW. Strickland Metals (STK): Strickland Metals Limited is a mineral exploration company focused on gold, copper, Zi, Pb, and Silver in Western Australia. Biotron Limited (BIT): Biotron Limited is a biotechnology company focused on the discovery and development of novel antiviral therapies for the treatment of HIV-1 and Hepatitis C virus (HCV). King River Resources (KRR): King River Resources is a gold explorer in the Kimberly region of WA and Tennant Creek in NT with copper as well.
ASX:BIT
by ch886
BIT BreakoutASX:BIT Biotron Limited is engaged in the research, development, and commercialization of drugs targeting significant viral diseases with unmet medical need. The Company has BIT225 in clinical development for HIV-1, and a promising preclinical program for HBV. In addition, Biotron has several earlier stage programs designing drugs that target a class of virus protein known as viroporins which have a key role in the virus life cycle of a very broad range of viruses, many of which have caused worldwide health issues such as Dengue, Ebola, Middle East Respiratory virus, Influenza and Zika viruses. Bullish Outlook: - If Daily Resistance fails I have a Golden Pocket Target after Identifying previous Breakout Cycles - Bullish Breakout from long-term downtrend - FIB Retracement Golden Pocket 0.5-0.618 has been previously respected - RSI Passed the 50.00 level and is now Bullish - MACD Bullish Cross "DISCLAIMER: NO ADVICE. The information presented here is general in nature and is for education purposes only. Nothing should be considered to be advice. You should consult with an appropriate professional for specific advice tailored to your situation."
ASX:BITLong
by Trader_Johnni
BIOTRON - Primed to MOVE!Watching BIOTRON closely. 2 Scenarios: 1. Break of internal trend within the symmetrical triangle will see us return to the .065-.080 region (AREA OF INTEREST). -We've had 2 bounces on the .382 Fib region creating a double top @ .115 Equilibrium -Break of internal uptrend trendline. -Currently broken the center band of bollinger bands. -We've also had a death cross on MACD and is starting to spread. -Waiting on break of support at .088 2. If POSITIVE results are announced shortly for any of BIOTRONS Projects/Programs (Anti Viral Drug Program, HIV Program, HBV Program) We should see a break out of Symmetrical Triangle. -Break of downtrend possible. -Retest of .011 Equilibrium VERY possible. -New Market Structure will form with Higher LOW & Higher HIGH. -Volume will be brought back into the market. -My next target would be major resistance at .014 A very interesting company with real world prospects. I have been following them since the earlier in the year, with Phase 2 HIV-1 Clinical Trials being successful, HBV Pre-Clinical Trials and work on Anti Viral Drug Development with a keen interest on Covid-19. These Ideas are NOT 'Financial Advice'!. Scenarios are based off a mixture of TA and Fundamentals current at the time. All IMO GLTAH. Happy Hunting!!!
ASX:BIT
by Trader_Johnni
2
BIT keeps rocking the cityAfter a recent retracement to 0.083 as I had showed the probability of such move, BIT is hitting 0.135 this is far more than what i thought could happen that soon but my target were to go beyond 0.1. I see some rsi bearish divergence and I have taken some profit. I will wait and see if it goes up again. If it falls below 1$ I am out, the upwards momentum will be dead for me. For those who traded this move with my TA hit the likes and put those thumbs up to the moon. I would like to see your comments. Cheers.
ASX:BIT
by xtf_ze_trader
Biotron Limited Advisory Board FormationBiotron was a big mover after announcing the establishment of an expert Scientific Advisory Board. The board is tasked with the responsibility of spearheading and overseeing the upcoming Phase 2 HIV-1 clinical development program. Chaired By professor Robert L Murphy, the board includes an international group of experts with vast experience in matters pertaining to HIV-1 as well as clinical development of HIV-1 therapies. The formation of the board comes hot on the heels of the company reporting positive results as part of BIT225-009 phase 2 HIV-1 clinical trial.
ASX:BIT
by Sector_Reports
$BIT:ASX - BIOTRON LIMITED - Promising progressTheir letter to shareholders didn't come out with much fanfare, but I like the space they are operating in. Couple of things that caught my eye was their successful trial in 2018 of their HIV product and they have spent the last year analysing the data out of it and they are soon holding a Scientific/Clinical Advisory Meeting with internationally recognised HIV-1 experts. This might give them a bit of a credibility bump and publicity which often comes out of these kinds of things as they release more PR around the meeting and the feedback. During the second half of 2019, they are planning to consult with the USA Food and Drug Administration (FDA) to ensure the proposed path is in accordance with relevant regulations. Also, the positive outcomes from the trial also mean that Biotron has been meeting with key potential partners with compelling Phase 2 data in hand. Phase 2 is generally considered the best time to license technology to a major pharmaceutical company as they have the expertise and resources necessary for late stage clinical development and regulatory approvals in major markets such as the USA Spiked up around 20% today on top of yesterdays run, so I'd want to see what happens tomorrow. Buyers and seller pretty evenly matched. Might be worth a watch. Biotron Limited (BIT) is a biotechnology company engaged in research, development, and commercialisation of drugs targeting viral diseases with unmet medical need. The Company focuses on the progression of the clinical development of the drug, BIT225, an investigational, orally-administered, novel antiviral compound in development by Biotron for treatment of HCV and HIV infections.
ASX:BITLong
by zAngus
THE DAY AFTER ...ASX:BIT EXPLODES 115% ACCORDING TO EXPECTATIONSHaving been 'oft times described as 'fashionably late' I AM VERY HAPPY to see My Projection of ASX:BIT (Biotron) follow the expected path of My Chart Projection. After a 'STELLAR' run throughout October 2018 ('SP' up 17X ) after officially announcing their BREAKTHROUGH Drug 'BIT 225' 's Phase 2 Clinical Trial success in taking a HUGE leap towards the COMPLETE ERADICATION of the HIV Virus - reporting a 100% eradication rate in a small sample of Infected patients, INEVITABLY a STRONG drawdown was due via the usual Profit Taking and SIGNIFICANT Short Selling by Professional Investors (should provide you a clue as to the potential long run VALUE on offer here..?) Well it would seem as of Today's Price Action that that dynamic has ended the day after I predicted it would with a VERY STRONG GREEN PRINT at VERY LARGE VOLUME rallying ASX:BIT 's 'SP' up 115% in ONE DAY..! Nice.. Given the HEAVY HITTER interest in this potential GLOBAL GAME CHANGER for the entire HIV treatment Market ...and the significant International attention such an innovation would attract; EXPECT VERY LARGE VOLUME TRADING and VERY VOLATILE Price Action whilst this Market for BIT's shares matures over the near term. Patient Long Holders as well as SKILLED/EXPERIENCED short term Speculators are presented with BOTH Opportunities for LARGE GAINS , over the long and short run respectively. For the inexperienced; I suggest your BEST Strategy is to go LONG and HOLD on for dear Life as the parties at play here, IF (?) you decide to Trade seeking quick easy Money, will chew you up, spit you out and leave you in the DIRT bloodied and crying like a Baby.. " O My Money, My Money! Dem bastards tricked me..! Oh Woah is me! " Well, suck it up Buttercup. That's the Market for you! I suggest to the 'one trick pony' Day Trader crew that may fall into this trap, try your local Casino. All IS fair in LOVE AND WAR and make no Mistake... TRADING IS NOT ABOUT LOVE! Lol. 'Investment' on the other hand is another Story.. If you cant take the heat don't even think about entering the Kitchen. Find a TRUSTED Professional Advisory that acts in YOUR BEST INTERESTS , not theirs, and let them do what they are trained to do without interfering unless you smell a RAT! Then act accordingly. If you lose all of your Money because you were too lazy to DO YOUR OWN RESEARCH and thought it a good idea to blindly accept some random strangers advice on Social Media (ie. Hot Schlopper ), don't come crying to 'Pappa'. He WONT help YOU over such a trifle as money. It just means you didn't do your own DUE DILIGENCE/RESEARCH thoroughly enough. Commiserations... NOT! Always DYOR. DISCLOSURE: I AM LONG ASX:BIT as both a Trader and Mid/Long Term Holder
ASX:BITLong
by craigemm
7
Price stablisation pending news to support directionRecent hype has pushed this stock up exponentially given successful news of their trial to target cells to eliminate AIDS, but what goes up must come down, so expecting it to hover close to the green support line and for its RSI to drop below.. 76-89 RSI expect a pullback (reliable) 36-39 RSI expect a rebound (only two indicators) Not enough data for a strong indication, but a rough estimation shows support at 24.5c. My guess is that it will bounce between 21c-28c and go either up if more good news released, or break this support and fall to around 16c-20c Also notice the big pump to 44c and dump to 31c. This stock is highly manipulated. Becareful trading. Given the nature of this stock, it is very high risk, but if you get a good entry, it's hype and pump will certainly bring more good news, or bad news cleverly disguised as good or okay news to hype it up more. Becareful of profit taking that will burn you.
ASX:BIT
by JasonThieu
7